APA (7th ed.) Citation

Li, X., Wang, H., Lin, S., & Chen, T. Efficacy and safety of PI3K inhibitors combined with fulvestrant for HR+/HER2− advanced breast cancer: A systematic review and meta-analysis. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Li, Xuefeng, Hongxian Wang, Shuhui Lin, and Tianwen Chen. Efficacy and Safety of PI3K Inhibitors Combined with Fulvestrant for HR+/HER2− Advanced Breast Cancer: A Systematic Review and Meta-analysis. Frontiers Media S.A.

MLA (9th ed.) Citation

Li, Xuefeng, et al. Efficacy and Safety of PI3K Inhibitors Combined with Fulvestrant for HR+/HER2− Advanced Breast Cancer: A Systematic Review and Meta-analysis. Frontiers Media S.A.